Disopyramide Phosphate Capsule, Extended Release — FDA Drug Shortage
The FDA lists a drug shortage record for Disopyramide Phosphate Capsule, Extended Release (capsule, extended release) from Pfizer Inc. with status To Be Discontinued. The shortage was first posted on 08/24/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Pfizer Inc.
- Package NDC
- 0025-2742-31
- Dosage Form
- Capsule, Extended Release
- Presentation
- Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31)
- Initial Posting
- 08/24/2026
- Revised Date